Secondary analyses are ongoing that may help understand predictors and mediators of successful weight loss, as well as analyses of secondary outcomes, including changes in glucose, lipid levels, and blood pressure; quality of life; and cost-effectiveness, she said.
SHINE was funded by the National Institute of Diabetes and Digestive and Kidney Disease. Dr. Trief reported having no financial disclosures.